Nebula Research & Development’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,588
Closed -$1.27M 937
2025
Q1
$1.27M Buy
+9,588
New +$1.22M 0.12% 286
2024
Q3
Sell
-17,178
Closed -$1.78M 905
2024
Q2
$1.78M Buy
17,178
+1,627
+10% +$173K 0.29% 78
2024
Q1
$1.77M Buy
+15,551
New +$1.78M 0.38% 32
2023
Q4
Sell
-9,971
Closed -$966K 621
2023
Q3
$966K Buy
+9,971
New +$1.05M 0.51% 9
2023
Q2
Sell
-2,221
Closed -$225K 327
2023
Q1
$225K Buy
+2,221
New +$235K 0.4% 157

Other funds holding ABT

Nebula Research & Development's ABT Position: Q2 2025 in Review

Nebula Research & Development sold out of Abbott (ABT) in Q2 2025, closing a stake of 9,588 shares — an estimated $1.27M sold.

Nebula Research & Development first reported a position in ABT in Q1 2023 and held it in 5 quarters. The position peaked at $1.78M in Q2 2024. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Nebula Research & Development reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • Nebula Research & Development sold 9,588 Abbott shares in Q2 2025, an estimated $1.27M.
  • Nebula Research & Development first reported a position in Abbott in Q1 2023 and held it in 5 quarters.
  • Nebula Research & Development's Abbott position peaked at $1.78M in Q2 2024.
  • 3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.